Literature DB >> 20613761

Diurnal blood pressure variation, risk categories and antihypertensive treatment.

Alejandro de la Sierra1, Julián Segura, Manuel Gorostidi, José R Banegas, Juan J de la Cruz, Luis M Ruilope.   

Abstract

Ambulatory blood pressure (BP) monitoring is a useful tool aiding diagnostic and management decisions in patients with hypertension. Diurnal BP variation or circadian rhythm adds prognostic value to the absolute BP elevation. The Spanish ABPM Registry has collected information from >30 000 treated hypertensive patients attended by either primary care physicians or referral specialists. The analysis of BP diurnal variation has allowed the conclusion that nocturnal BP decline is related to the level of risk. Patients with blunted nocturnal dip frequently belong to high- or very high-risk categories and specifically are often older, obese, diabetics or with overt cardiovascular or renal disease. With respect to treatment, the non-dipper profile is more often observed in patients receiving several antihypertensive drug agents, but it does not correlate with the time of drug administration. Among patients receiving only one drug, non-dihydropyridine calcium channel blockers and alpha-blockers are associated with less nocturnal BP decline than other antihypertensive drug classes, even after adjusting for the level of risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20613761     DOI: 10.1038/hr.2010.111

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  19 in total

Review 1.  Is it possible to manage hypertension and evaluate therapy without ambulatory blood pressure monitoring?

Authors:  William B White; Spyridoula Maraka
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

2.  Nighttime blood pressure dipping in postmenopausal women with coronary heart disease.

Authors:  Andrew Sherwood; Julie K Bower; Faye S Routledge; James A Blumenthal; Judith A McFetridge-Durdle; L Kristin Newby; Alan L Hinderliter
Journal:  Am J Hypertens       Date:  2012-07-12       Impact factor: 2.689

Review 3.  Managing hypertension with ambulatory blood pressure monitoring.

Authors:  William B White; Vinay Gulati
Journal:  Curr Cardiol Rep       Date:  2015-02       Impact factor: 2.931

4.  Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysis.

Authors:  Thomas D Giles; Thomas Alessi; Das Purkayastha; Dion Zappe
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-16       Impact factor: 3.738

5.  Agreement between community pharmacy and ambulatory and home blood pressure measurement methods to assess the effectiveness of antihypertensive treatment: the MEPAFAR study.

Authors:  Daniel Sabater-Hernández; Alejandro De La Sierra; Pablo Sánchez-Villegas; Fidelina M Santana-Pérez; Luisa Merino-Barber; María J Faus
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-05       Impact factor: 3.738

6.  Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension.

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Michael Doumas
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-13       Impact factor: 3.738

7.  The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.

Authors:  Marguerite R Irvin; John N Booth; Mario Sims; Adam P Bress; Marwah Abdalla; Daichi Shimbo; David A Calhoun; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-13       Impact factor: 3.738

8.  Out-of-office blood pressure: from measurement to control.

Authors:  Jean-Philippe Baguet
Journal:  Integr Blood Press Control       Date:  2012-05-16

9.  Carotid atherosclerosis and the association between nocturnal blood pressure dipping and cardiovascular events.

Authors:  Praew Kotruchin; Satoshi Hoshide; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-16       Impact factor: 3.738

10.  Factors associated with blood pressure control in hypertensive patients with coronary heart disease: evidence from the Chinese Cholesterol Education Program.

Authors:  Dachun Xu; Wei Chen; Xiankai Li; Yi Zhang; Xin Li; Hou Lei; Yidong Wei; Weiming Li; Dayi Hu; Nicole M Wedick; Jinsong Wang; Yawei Xu; Jue Li; Yunsheng Ma
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.